Browsing Tag
Janssen Pharmaceuticals
14 posts
Leyden Labs secures €20m from European Investment Bank: Could this reshape Europe’s pandemic response strategy?
Leyden Labs secures €20M EIB funding under HERA Invest to develop intranasal antibody sprays targeting pandemic flu and respiratory threats.
Lupin gets US FDA nod for generic Xarelto; Eyes $8bn anticoagulant market
Lupin wins FDA approval for generic Xarelto, unlocking access to a USD 8 billion U.S. anticoagulant market. Find out what this means for investors and rivals.
Aurobindo Pharma wins key FDA approval for blockbuster blood thinner in $8.5bn US market
Aurobindo Pharma gets USFDA final approval for Rivaroxaban 2.5mg and tentative nod for other doses. Find out what this means for its US market strategy.
Alembic Pharmaceuticals secures USFDA approval for new Paliperidone extended-release tablets
Alembic Pharmaceuticals Limited has achieved a major milestone in the pharmaceutical industry. On September 27, 2024, the company…
Indoco Remedies secures FDA tentative approval for Canagliflozin Tablets
Indoco Remedies Ltd., a renowned player in the global pharmaceutical industry, has announced receiving tentative approval from the…
Lupin obtains tentative FDA approval for generic Canagliflozin Tablets
Global pharmaceutical leader, Lupin Limited, announced its significant achievement of receiving tentative approval from the United States Food…
Janssen Covid‑19 vaccine gets conditional marketing authorization in EU
The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed…
ViiV Healthcare’s Cabenuva secures FDA approval for HIV treatment
ViiV Healthcare has received FDA approval for Cabenuva, a long-acting treatment regimen for HIV-1 infection in adult patients.…
Janssen acquires HMR59 from Hemera for geographic atrophy treatment
Janssen Pharmaceuticals has secured the rights to an innovative gene therapy, HMR59, for the treatment of geographic atrophy,…
Johnson & Johnson strikes key deal with EC for JNJ-78436735 Covid-19 vaccine supply
Johnson & Johnson (J&J) has announced a significant development in its efforts to combat the Covid-19 pandemic, revealing…